Novartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, ...

The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...

The FDA will decide on new drugs for rosacea, AADC deficiency, breast cancer, transthyretin amyloid cardiomyopathy, and biliary tract cancer.

The Food and Drug Administration expanded the approval of Kisqali, a drug for metastatic breast cancer, to also treat ...

Vas Narasimhan, CEO of Novartis, comments on the progress of the firm's Kisqali metastatic breast cancer drug after the company recently received an extended approval for it from the U.S. Food and ...

The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...

John Maraganore, the former CEO of Alnylam Pharmaceuticals, launched City Therapeutics, a new startup with $135 million from ...

Lexington biotech Aldeyra is trying once again to win approval for its dry eye disease drug, called reproxalap, after an FDA ...

Radiopharmaceuticals have been used to treat patients with prostate cancer for decades, but experts say there is more to ...

This led to the approval of drugs such as Wegovy for obesity treatment that act by suppressing appetite and increasing fat burning. The benefits do not stop there. Recent studies suggest GLP-1 drugs ...

This led to the approval of drugs such as Wegovy for obesity treatment that act by suppressing appetite and increasing fat burning. The benefits do not stop there. Recent studies suggest GLP-1 drugs ...

Pharmaceutical companies are demonstrating innovation by not only developing new drugs but also exploring combination therapies and repurposing existing drugs to address unmet medical needs.